Hosted on MSN

Experimental drug shown to slow multiple sclerosis disability

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...
Medical Xpress

Oral bacterium tied to disability severity in multiple sclerosis

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders through chronic inflammation. However, its role in multiple sclerosis, a ...
Seeking Alpha

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...
The American Journal of Managed Care

Variation in Systolic BP Appears to Correlate With Multiple Sclerosis Disability

A new study suggests patients whose systolic blood pressure varies significantly over time might be at greater risk of higher multiple sclerosis disability. Patients with multiple sclerosis (MS) who ...
Morningstar

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) – Late-breaking Phase III FENtrepid ...
Forbes

5 Simple Ways To Support Disability Activism

Forbes contributors publish independent expert analyses and insights. Andrew Pulrang writes about disability practices, policy, and culture. Disability activism is empowering. For some disabled people ...